Story Navigation
-
Access to HealthcareAccess to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical DiseasesJun 21, 2022Renewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaChildren's HealthNovartis AccessJun 16, 2022Sickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to Healthcare -
DiscoveryCancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in ScienceJun 10, 2022A shared mission to take on the “impossible” in cancer researchDiscovery
-
Access to HealthcareAccess to HealthcareCancerOncologySocial CommitmentTargeted TherapyJun 7, 2022Prostate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Access to Healthcare -
DiscoveryCancerCell and Gene TherapyChildren's HealthNovartis Institutes for BioMedical ResearchOncologyMay 24, 2022How Emily’s act of bravery inspired a wave of continued innovation
Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
Discovery -
Access to HealthcareAccess to HealthcareCancerNovartis AccessSocial CommitmentMay 19, 2022Boosting access to cancer care where it’s needed most
Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.
Access to Healthcare -
Access to HealthcareAccess to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical DiseasesApr 7, 2022Staying one step ahead of the malaria parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to Healthcare -
Access to HealthcareChronic IllnessEnvironmental SustainabilityInfectious DiseasesMalariaNovartis Institutes for BioMedical ResearchApr 4, 2022Tackling the health toll of climate changeAccess to Healthcare
-
Patient PerspectivesMar 21, 2022Understanding hidradenitis suppurativa through Jasmine’s eyesPatient Perspectives
-
Access to HealthcareAccess to HealthcareCardiovascular DiseaseHeart DiseaseNovartis AccessMar 1, 2022Prioritizing the needs of patientsAccess to Healthcare
-
From Our LabsCancerClinical ResearchInnovationOncologyScientific ResearchDec 1, 2021When it comes to cancer, there’s power in a good partner
Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.
From Our Labs -
DiscoveryBiomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging TechnologyNov 15, 2021The art of drug design in a technological age
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
Discovery